statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the Company or MindMed), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders, today presented...

MindMed Presents Phase 2b Study of MM120 for Generalized Anxiety Disorder (GAD) at American Psychiatric Association (APA) Annual Meeting in New York

Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the Company or MindMed), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders, announced today...

MindMed to Host Conference Call and Webcast to Discuss First Quarter 2024 Financial Results and Provide Business Update

Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (the Company or MindMed), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders, announced today...

MindMed to Present at Upcoming May Medical Conferences

Shares of Mind Medicine (MindMed) Inc. MNMD have skyrocketed 154% in the past three months against the industry's decline of 4.2%.The company is progressing well with the development of its lead...

MindMed (MNMD) Stock Rises 154% in 3 Months: Here's Why

Shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD - Get Free Report) hit a new 52-week high during trading on Wednesday . The company traded as high as $11.85 and last traded at $11.69, with a...

Mind Medicine (MindMed) (NASDAQ:MNMD) Sets New 12-Month High at $11.85

Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (Cboe Canada: MMED), (the Company or MindMed), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health...

MindMed to Present at Upcoming April Medical Conferences

Shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD - Get Free Report) traded down 1.7% during trading on Tuesday . The stock traded as low as $8.97 and last traded at $9.36. 489,301 shares changed...

Mind Medicine (MindMed) (NASDAQ:MNMD) Stock Price Down 1.7%

Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (Cboe Canada: MMED) (the Company or MindMed), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health...

MindMed Announces Voluntary Delisting from Cboe Canada

Mind Medicine (MindMed) Inc. (NASDAQ:MNMD - Get Free Report)'s share price traded up 4.5% during trading on Thursday . The stock traded as high as $9.94 and last traded at $9.93. 617,016 shares...

Mind Medicine (MindMed) (NASDAQ:MNMD) Trading 4.5% Higher

Mind Medicine (MindMed) Inc. (NASDAQ:MNMD  Get Free Report) insider Dan Karlin sold 6,578 shares of the stock in a transaction dated Monday, March 25th. The shares were sold at an average...

Dan Karlin Sells 6,578 Shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Stock

Mind Medicine (MindMed), Inc. operates as clinical stage biopharmaceutical company, which engages in developing novel product candidates to treat brain health disorders. The company was founded by Stephen L. Hurst, Scott M. Freeman, Leonard Latchman and Jamon Alexander Rahn in 2019 and is headquartered in New York, NY.

Watchers	25,114
52-Wk Low	$2.41
52-Wk High	$12.22

Volume	302,892.00
52-Wk High	$12.22
52-Wk Low	$2.41

MNMD Mind Medicine Inc - Ordinary Shares (Sub Voting)

About

Feed

News

Sentiment

Earnings

Fundamentals